APA (7th ed.) Citation

Rowe, S. M., Heltshe, S. L., Gonska, T., Donaldson, S. H., Borowitz, D., Gelfond, D., . . . Ramsey, B. W. (2014). Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis. American journal of respiratory and critical care medicine, 190(2), 175-184. https://doi.org/10.1164/rccm.201404-0703OC

Chicago Style (17th ed.) Citation

Rowe, Steven M., et al. "Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis." American Journal of Respiratory and Critical Care Medicine 190, no. 2 (2014): 175-184. https://doi.org/10.1164/rccm.201404-0703OC.

MLA (9th ed.) Citation

Rowe, Steven M., et al. "Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis." American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 2, 2014, pp. 175-184, https://doi.org/10.1164/rccm.201404-0703OC.